Serum concentrations of immunoglobulins in patients with epilepsy treated with carbamazepine

Acta Neurologica Scandinavica

Volumn 61, Issue 4, 1980, Pages 260-263

  Strandjord, R E ^a,b   Johannessen, S I ^a,b   Aarli, J A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b National Center for Epilepsy   (Norway)

Author keywords

Carbamazepine; IgA; IgG; IgM; monotherapy; serum concentrations

Indexed keywords

CARBAMAZEPINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

AGE; CENTRAL NERVOUS SYSTEM; DRUG THERAPY; EPILEPSY; FOCAL EPILEPSY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; THERAPY;

CARBAMAZEPINE; EPILEPSIES, PARTIAL; FEMALE; HUMAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; MALE;

EID: 0018889259     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1980.tb01491.x     Document Type: Article

References (13)

1. Drug‐induced IgA deficiency in epileptic patients
2. Effect of antiepileptic drugs on serum and salivary IgA
3. IgA deficiency, epilepsy and hydantoin medication
4. Effect of phenytoin on the immune response in rabbits
5. Immunological abnormalities and hydantoins
6. IgA deficiency, epilepsy and phenytoin treatment
7. Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants
8. A comparative controlled study between carbamazepine and diphenyl‐hydantoin in psychomotor epilepsy
9. Serum immunoglobulins in epilepsy
10. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro
11. Depression of immunological function in patients treated with phenytoin sodium (diphenylhydantoin)
12. IgA deficiency and systemic lupus erythematosus